Katanosin B and Plusbacin A 3 , Inhibitors of Peptidoglycan Synthesis in Methicillin-Resistant Staphylococcus aureus
Authors:
- 1 June 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (6) , 1823-1827
Abstract
Both katanosin B and plusbacin A 3 are naturally occurring cyclic depsipeptide antibiotics containing a lactone linkage. They showed strong antibacterial activity against methicillin-resistant Staphylococcus aureus and VanA-type vancomycin-resistant enterococci, with MICs ranging from 0.39 to 3.13 μg/ml, as well as against other gram-positive bacteria. They inhibited the incorporation of N -acetylglucosamine, a precursor of cell wall synthesis, into peptidoglycan of S. aureus whole cells at concentrations close to their MICs. In vitro studies with a wall-membrane particulate fraction of S. aureus showed that katanosin B and plusbacin A 3 inhibited the formation of lipid intermediates, with 50% inhibitory concentrations (IC 50 s) of 2.2 and 2.3 μg/ml, respectively, and inhibited the formation of nascent peptidoglycan, with IC 50 s of 0.8 and 0.4 μg/ml, respectively. Vancomycin, a well-known inhibitor of transglycosylation, did not inhibit the formation of lipid intermediates but did inhibit the formation of nascent peptidoglycan, with an IC 50 of 4.1 μg/ml. Acetyl-Lys- d -Ala- d -Ala, an analog of the terminus of the lipid intermediates, effectively suppressed the inhibition of transglycosylation by vancomycin, but did not suppress those by katanosin B and plusbacin A 3 . These results indicate that the antibacterial activity of katanosin B and plusbacin A 3 is due to blocking of transglycosylation and its foregoing steps of cell wall peptidoglycan synthesis via a mechanism differing from that of vancomycin.Keywords
This publication has 43 references indexed in Scilit:
- Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal BacteremiaEmerging Infectious Diseases, 1999
- Identification of three additionalfemAB-like open reading frames inStaphylococcus aureusFEMS Microbiology Letters, 1999
- Staphylococcal Peptidoglycan Interpeptide Bridge Biosynthesis: A Novel Antistaphylococcal Target?Microbial Drug Resistance, 1996
- Nucleotide sequence of the structural gene for the penicillin-binding protein 2 ofStaphylococcus aureusand the presence of a homologous gene in other staphylococciFEMS Microbiology Letters, 1994
- Inhibition of peptidoglycan biosynthesis in Bacillus megaterium by daptomycinFEMS Microbiology Letters, 1990
- THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUPAnnual Review of Microbiology, 1984
- Molecular divergence of a major peptidoglycan synthetase with transglycosylase - transpeptidase activities in Escherichia coli — Penicillin-binding protein 1BsBiochemical and Biophysical Research Communications, 1982
- Peptidoglycan synthetic enzyme activities of highly purified penicillin-binding protein 3 in Escherichia coli: A septum-forming reaction sequenceBiochemical and Biophysical Research Communications, 1981
- Dual enzyme activities of cell wall peptidoglycan synthesis, peptidoglycan transglycosylase and penicillin-sensitive transpeptidase, in purified preparations of Escherichia coli penicillin-binding protein 1ABiochemical and Biophysical Research Communications, 1980
- Acute Infection of Mice with Smith Strain of Staphylococcus aureusScience, 1958